APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $65,000 | -69.3% | 950 | -77.3% | 0.00% | -71.4% |
Q1 2022 | $212,000 | +488.9% | 4,181 | +449.4% | 0.01% | +600.0% |
Q4 2021 | $36,000 | -87.8% | 761 | -91.5% | 0.00% | -90.0% |
Q3 2021 | $296,000 | -22.7% | 8,979 | +48.2% | 0.01% | -16.7% |
Q2 2021 | $383,000 | +2846.2% | 6,057 | +1289.2% | 0.01% | +1100.0% |
Q3 2020 | $13,000 | -69.8% | 436 | -67.2% | 0.00% | -80.0% |
Q2 2020 | $43,000 | +43.3% | 1,330 | +19.2% | 0.01% | -61.5% |
Q1 2020 | $30,000 | +2900.0% | 1,116 | +2690.0% | 0.01% | – |
Q3 2019 | $1,000 | -66.7% | 40 | -70.8% | 0.00% | -100.0% |
Q1 2019 | $3,000 | 0.0% | 137 | -41.9% | 0.00% | 0.0% |
Q4 2018 | $3,000 | – | 236 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |